METHODS OF MODULATING HVEM, BTLA AND CD160 CIS COMPLEX RESPONSE OR SIGNALING ACTIVITY WITH SOLUBLE LIGHT POLYPEPTIDE SEQUENCES

Number of patents in Portfolio can not be more than 2000

United States of America Patent

SERIAL NO

12534658

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention provides HVEM cis complexes which include, for example, HVEM/BTLA, HVEM/CD160 and HVEM/gD cis complexes. The invention provides ligands and agents that bind to HVEM cis complexes, such as antibodies. The invention further provides methods of use of the HVEM cis complexes, and the ligands and agents (e.g., LIGHT polypeptide sequence) that bind to the HVEM cis complexes.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY9420 ATHENA CIRCLE SAN DIEGO CA 92037

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Cheung, Timothy C Wollstonecraft, AU 6 34
Steinberg, Marcos San Diego, US 5 14
WARE, CARL F Solana Beach, US 27 203

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation